I wouldn't be surprised to see a takeover offer for Solagran as...

I wouldn't be surprised to see a takeover offer for Solagran as the Market cap is so low and good income is expected in the near future.
Once Ropren hits the market in Russia, it should be able to be bought worldwide over the internet, this is why Solagran is increasing the production capacity ready for the demand.
With a market cap of less than $11M and the top 20 owning more than 70% of the shares this should move up fast.
Plus with TGA approval in Australia already granted for Bioeffective A and with a robust research program advancing well, this stock should be a winner.

For those who know little about this up and coming biotech, do some research, as it may reward you as it already has for me. The next 12 months will be the most exciting for all the current investors.

Please do your own research and make your own decisions before buying anything.

I hold SLA SLACD